Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Park, Sejeong, Park, So Young, Kim, Yu Jin, Hong, Soo Min, Chon, Suk, Oh, Seungjoon, Woo, Jeong-taek, Kim, Sung-Woon, Kim, Young Seol, Rhee, Sang Youl
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929228/
https://ncbi.nlm.nih.gov/pubmed/27098506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.3.240
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados